MAPS (Multidisciplinary Association for Psychedelic Studies)
is a membership-based organization working to assist researchers
worldwide to design, fund, conduct, obtain governmental approval
for, and report on psychedelic research in humans. Founded
in 1986, MAPS is an IRS approved 501 (c)(3) non-profit corporation
funded by tax deductible donations.
MAPS is focused primarily on assisting scientists to conduct
human studies to generate essential information about the
risks and psychotherapeutic benefits of MDMA, other psychedelics,
and marijuana, with the goal of eventually gaining government
approval for their medical uses.
Interested parties wishing to copy any portion of this publication
are encouraged to do so and are kindly requested to credit
MAPS and include our address. The MAPS Bulletin is produced
by a small group of dedicated staff and volunteers. Your participation,
financial or otherwise, is welcome.